39,624 Shares in Bruker Corporation $BRKR Purchased by Voleon Capital Management LP

Key Points

• Voleon Capital Management LP acquired 39,624 shares of Bruker Corporation, valued at approximately $1,654,000, during the first quarter of the year.
• Bruker Corporation reported a quarterly earnings miss, with earnings per share of $0.32, falling short of the consensus estimate of $0.33.
• The company declared a $0.05 quarterly dividend to be paid on October 3rd, representing an annualized dividend yield of 0.6%.

Voleon Capital Management LP acquired a new stake in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 39,624 shares of the medical research company's stock, valued at approximately $1,654,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Pinnacle Bancorp Inc. bought a new stake in Bruker during the first quarter worth $29,000. Allworth Financial LP grew its holdings in Bruker by 92.4% during the first quarter. Allworth Financial LP now owns 758 shares of the medical research company's stock worth $30,000 after buying an additional 364 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in Bruker by 1,354.5% during the first quarter. Caitong International Asset Management Co. Ltd now owns 800 shares of the medical research company's stock worth $33,000 after buying an additional 745 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC bought a new stake in Bruker during the first quarter worth $42,000. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Bruker by 274.9% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,091 shares of the medical research company's stock worth $46,000 after buying an additional 800 shares in the last quarter. Institutional investors own 79.52% of the company's stock.

Insider Activity at Bruker

In other news, Director Cynthia M. Friend sold 3,535 shares of the company's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the transaction, the director owned 18,016 shares of the company's stock, valued at $581,016. This represents a 16.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 27.30% of the stock is owned by corporate insiders.

Bruker Stock Performance

BRKR stock traded down $1.16 during midday trading on Friday, hitting $30.91. The company's stock had a trading volume of 2,838,988 shares, compared to its average volume of 4,224,383. The stock's 50-day moving average price is $36.02 and its 200 day moving average price is $38.83. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 1 year low of $28.53 and a 1 year high of $72.94. The stock has a market cap of $4.69 billion, a price-to-earnings ratio of 59.44, a PEG ratio of 4.29 and a beta of 1.22.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm had revenue of $797.40 million for the quarter, compared to analysts' expectations of $811.17 million. During the same period in the prior year, the company earned $0.52 EPS. The firm's quarterly revenue was down .4% on a year-over-year basis. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, equities analysts forecast that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 23rd. Bruker's dividend payout ratio is currently 38.46%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Bank of America decreased their price target on Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Wells Fargo & Company decreased their price target on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a "hold" rating in a report on Tuesday, August 5th. Jefferies Financial Group set a $60.00 price objective on Bruker and gave the stock a "buy" rating in a research report on Monday, August 4th. Finally, Citigroup cut their price objective on Bruker from $40.00 to $38.00 and set a "neutral" rating on the stock in a research report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $51.30.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.